Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/03/2008EP1996197A1 Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof
12/03/2008EP1996196A2 Somatostatin agonists
12/03/2008EP1996195A2 Hydroxylamines and derivatives for the inhibition of complement activation
12/03/2008EP1996194A2 Homotropanes with central nervous system activity
12/03/2008EP1996193A2 Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
12/03/2008EP1996191A2 Thiazolones for use as pi3 kinase inhibitors
12/03/2008EP1996190A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators
12/03/2008EP1996189A1 Benzimidazoles which have activity at m1 receptor and their uses in medicine
12/03/2008EP1996188A1 Benzimidazoles which have activity at m1 receptor and their uses in medicine
12/03/2008EP1996187A2 Methods and compositions for treating fish diseases
12/03/2008EP1996185A2 Treatment or prevention of scarring, capsular contractures and/or hyperpigmentation using leukotriene receptor antagonist and vitamin e
12/03/2008EP1996184A2 Small molecule apoptosis promoters
12/03/2008EP1996183A1 Method of treatment or prophylaxis inflammatory pain
12/03/2008EP1996182A2 Cancer treatment with gamma-secretase inhibitors
12/03/2008EP1996181A1 Cardioplegic solution
12/03/2008EP1996180A1 Antibacterial agents
12/03/2008EP1996179A2 Compositions for disorders associated with metachromatic cell activation
12/03/2008EP1996177A2 Agents for influencing receptors and consequences thereof
12/03/2008EP1996176A2 Compositions to reduce blood glucose levels and treat diabetes
12/03/2008EP1996175A1 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
12/03/2008EP1996174A2 Methods of treating influenza viral infections
12/03/2008EP1996169A2 Controlled release formulation of tolterodine
12/03/2008EP1996162A2 Methods and compositions for treatment of diastolic heart failure
12/03/2008EP1996161A2 Nanoparticulate carvedilol formulations
12/03/2008EP1996137A2 Fluidic tissue augmentation compositions and methods
12/03/2008EP1996118A2 Hmg co-a reductase inhibitor enhancement of bone and cartilage
12/03/2008EP1996022A2 Modulation of innate immunity receptors' signaling by micrornas mir-146a and mir-146b
12/03/2008EP1996021A2 Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
12/03/2008EP1996020A2 Purine compounds and methods of use thereof
12/03/2008EP1945734A4 Polycationic viscoelastic compositions
12/03/2008EP1906931B1 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof
12/03/2008EP1906921B1 Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation
12/03/2008EP1855677B1 3,11b cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses
12/03/2008EP1838291A4 Pharmaceutical formulations and methods of use
12/03/2008EP1831230B1 Process for obtaining levofloxacin free from salts
12/03/2008EP1827373B1 Ophthalmic emulsions containing prostaglandins
12/03/2008EP1818059B1 Preventive or therapeutic agent for glaucoma
12/03/2008EP1804807B1 Coadministration of tigecycline and digoxin
12/03/2008EP1784482A4 Transgenic mammals and cell lines for the identification of glutamate transporter modulators
12/03/2008EP1778633B1 Indoles useful in the treatment of inflammation
12/03/2008EP1776340B1 N-(1h-indolyl)-h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use
12/03/2008EP1761262B1 Marine compounds with calcium channel blocking properties for the treatment of cognitive or neurodegenerative diseases
12/03/2008EP1751153B1 Hetaryloxy-substituted phenylamino pyrimidines as rho kinase inhibitors
12/03/2008EP1740584B1 Fused quinoline derivative and use thereof
12/03/2008EP1737463B1 Pyrimidines with tie2 (tek) activity
12/03/2008EP1711507B1 Crystalline form of risedronate monosodium
12/03/2008EP1709043B1 Pyrrolopyridine-substituted benzol derivatives for treating cardiovascular diseases
12/03/2008EP1682152A4 Compositions and methods for treatment of nervous system disorders
12/03/2008EP1663192B1 hERG1 CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS
12/03/2008EP1651189B1 Novel metaxalone compositions
12/03/2008EP1643976B1 Pharmaceutical formulation comprising levothyroxine sodium
12/03/2008EP1610771B1 Use of an alpha2-adrenoceptor antagonist for the treatment of epilepsy
12/03/2008EP1560573B1 Use of n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicyclo[2.2.1]hept-1-ylmethanesulfonamide family members in therapy
12/03/2008EP1549615B1 Naphthamide derivatives and their use
12/03/2008EP1541554B1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
12/03/2008EP1538980A4 Devices and methodologies useful in body aesthetics
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
12/03/2008EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof
12/03/2008EP1461004B1 Dialkyl-substituted acetic acid and glyceric acid based active substance combinations against bacteria, mycota and viruses
12/03/2008EP1458700B1 Substituted 2-phenyl benzofurans as estrogenic agents
12/03/2008EP1430031B1 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
12/03/2008EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
12/03/2008EP1423105B1 Combinations of dmxaa and other anti-cancer agents
12/03/2008EP1419129B1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
12/03/2008EP1390045B1 The use of a compound with a negatively charged domain of phosphorous-containing radicals for the treatment of restenosis
12/03/2008EP1389101B1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof
12/03/2008EP1383787B1 Sapogenin derivatives, their synthesis and use
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands
12/03/2008EP1318799B1 Stable dosage forms containing ubiquinones
12/03/2008EP1313462B1 Use of asiatic acid or asiaticoside for treatment of cancer
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
12/03/2008EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide
12/03/2008EP1297828B1 Oral formulations for localized colonic release and the method of preparation thereof
12/03/2008EP1251844B1 Laxative preparation containing l-arginine
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008EP1213975B1 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado
12/03/2008EP1187632B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
12/03/2008EP1175217B1 (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
12/03/2008EP1079804B1 Pharmaceutical compositions comprising an amphoteric surfactant an polypropoxylated cetyl alcohol and a polar drug
12/03/2008EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
12/03/2008EP1028961B3 Pleuromutilin derivatives as antimicrobials
12/03/2008EP0900200B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
12/03/2008CN101316934A Pde inhibitors and combinations thereof for the treatment of urological disorders
12/03/2008CN101316863A Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques
12/03/2008CN101316858A Sulfamoyl sulfonate prodrugs
12/03/2008CN101316857A Prodrug ER-beta-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
12/03/2008CN101316856A Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same
12/03/2008CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators
12/03/2008CN101316851A Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
12/03/2008CN101316850A Substituted aminophenylsulfonamide compounds as HIV protease inhibitor
12/03/2008CN101316849A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/03/2008CN101316848A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
12/03/2008CN101316847A Pyrazolo(1, 5A) pyrimidines as protein kinase inhibitors
12/03/2008CN101316846A Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia
12/03/2008CN101316845A Fused bicyclic mTOR inhibitors
1 ... 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 ... 7860